Assessing a 12-month course of oral alendronate for adults with avascular necrosis of the hip: MANTIS RCT with internal pilot

Assessing a 12-month course of oral alendronate for adults with avascular necrosis of the hip: MANTIS RCT with internal pilot

Background: People with avascular necrosis of the hip have very limited treatment options currently available to stop the progression of this disease; this often results in the need for a hip replacement. There is some weak evidence that a class of drugs called bisphosphonates may delay the course o...

Full description

Bibliographic Details
Main Authors: Sion Glyn-Jones, Muhammad K Javaid, David Beard, Julia Newton, Robert Kerslake, Callum McBryde, Tim Board, Susan J Dutton, Melina Dritsaki, Vikas Khanduja, Magbor Akanni, Shaun Sexton, John Skinner, Nicholas Peckham, Ruth Knight, Ines Rombach, Loretta Davies, Vicki Barber
Format: Article
Language:English
Published: NIHR Journals Library 2022-10-01
Series:Health Technology Assessment
Subjects:
avascular necrosis
alendronate
hip replacement
Online Access:https://doi.org/10.3310/AVZV0799

Internet

https://doi.org/10.3310/AVZV0799

Similar Items